The latest financial statement is for the year ending 2026-03-31.
| Cash Flow | 2026-03-31 |
|---|---|
| Total adjusted ebitda | 744,264 |
| Interest (expense) income, net | -207,226 |
| Income tax benefit (provision) | 8,468 |
| Depreciation, amortization and product development amortization | 361,918 |
| Restructuring and cost savings implementation charges | 11,176 |
| Advisory fees | 3,125 |
| Impairment charge | 39,000 |
| Purchase accounting | 0 |
| Transaction and integration costs | 1,191 |
| Stock-based compensation | 33,723 |
| Gain (loss) on extinguishment of debt | -25,766 |
| Other | 17,351 |
| Net income (loss) | 35,320 |
| Amortization of inventory purchase accounting adjustments | 0 |
| Depreciation (including amortization of technology costs) | 81,985 |
| Amortization of intangibles | 223,627 |
| Amortization of product development costs | 56,306 |
| Amortization of capitalized contract costs-Royalty | 76,186 |
| Amortization of capitalized contract costs-Commission Costs | 22,449 |
| Stock-based compensation | 33,723 |
| Credit losses on accounts receivable | 2,309 |
| Unrealized (gain) loss on interest rate cap | 0 |
| Inventory obsolescence | 9,186 |
| Deferred income taxes | -1,055 |
| Amortization of debt discount | 13,000 |
| Amortization of deferred financing costs | 4,943 |
| (gain) loss on extinguishment of debt | -25,766 |
| Gain on disposition | 0 |
| Impairment charge | 39,000 |
| Accounts receivable | 22,902 |
| Inventories | 29,467 |
| Prepaid and other current assets | 127,979 |
| Accounts payable and accrued expenses | -21,265 |
| Deferred revenue | -6,174 |
| Other current liabilities | -84,192 |
| Other changes in operating assets and liabilities, net | -407 |
| Cash provided by (used for) operating activities | 331,173 |
| Product development expenditures | 119,001 |
| Capital expenditures | 84,862 |
| Proceeds from disposition | 0 |
| Acquisition of essaypop | 0 |
| Cash provided by (used for) investing activities | -203,863 |
| Borrowings on 2024 secured notes | 0 |
| Borrowings on abl revolving credit facility | 0 |
| Payment of term loan facility and secured notes-AECash Flow Credit Facilities AETerm Loan Facility | 605,575 |
| Payment of term loan facility and secured notes-Term Loan Facility | 0 |
| Payment of abl revolving credit facility | 0 |
| Repurchase of 2022 unsecured notes | 39,895 |
| Payment of deferred financing costs | 0 |
| Payment of finance lease obligations | 6,722 |
| Proceeds from issuance of common stock in initial public offering, net of underwriting discounts | 392,862 |
| Deferred initial public offering costs | 7,037 |
| Issuance of common stock | 1,500 |
| Cash provided by (used for) financing activities | -264,867 |
| Effect of exchange rate changes on cash | 1,246 |
| Net change in cash and cash equivalents | -136,311 |
| Cash and cash equivalents, at the beginning of the period | 389,830 |
| Cash and cash equivalents, at the end of the period | 253,519 |
McGraw Hill, Inc. (MH)
McGraw Hill, Inc. (MH)